Advertisement
YOU ARE HERE: LAT HomeCollectionsOcular Sciences Inc
IN THE NEWS

Ocular Sciences Inc

FEATURED ARTICLES
BUSINESS
July 29, 2004 | From Reuters
Vision care products maker Cooper Cos. said that it agreed to buy rival Ocular Sciences Inc. for $1.2 billion in cash and stock, in a bid to create the world's third-largest contact lens company. Pleasanton, Calif.-based Cooper said it was offering $44 a share in cash and stock for Ocular, including $600 million in cash and 10.3 million new Cooper shares. Ocular Sciences, based in Concord, Calif., is the No. 5 maker of contact lenses and has projected 2004 revenue of $342.4 million.
ARTICLES BY DATE
BUSINESS
July 29, 2004 | From Reuters
Vision care products maker Cooper Cos. said that it agreed to buy rival Ocular Sciences Inc. for $1.2 billion in cash and stock, in a bid to create the world's third-largest contact lens company. Pleasanton, Calif.-based Cooper said it was offering $44 a share in cash and stock for Ocular, including $600 million in cash and 10.3 million new Cooper shares. Ocular Sciences, based in Concord, Calif., is the No. 5 maker of contact lenses and has projected 2004 revenue of $342.4 million.
Advertisement
BUSINESS
April 29, 1992 | JAMES M. GOMEZ, TIMES STAFF WRITER
Allergan Inc. said Tuesday that it has agreed to sell its contact-lens business in North and South America to a San Francisco firm, saying that profits from the 5-year-old venture have been disappointing. Ocular Sciences Inc., a contact-lens manufacturer, has signed the agreement to take over Allergan's four contact-lens production facilities. One facility is in Toronto and three more are in Santa Isabel, Puerto Rico. The sale is expected to be completed in midsummer, company officials said.
BUSINESS
November 5, 1992 | From Times Staff and Wire Reports
Allergan Completes Sale to Competitor: Irvine-based Allergan Inc. said Wednesday that it has finalized the sale of its U.S. and South America contact-lens business to a competitor. The sale of the business to Ocular Sciences in San Francisco was announced in April. Company officials said that Allergan was selling off the segment of its operations because it is too competitive and because the company wants to concentrate on its line of pharmaceuticals for eyes and skin.
BUSINESS
November 5, 1992 | From Times Staff and Wire Reports
Allergan Completes Sale to Competitor: Irvine-based Allergan Inc. said Wednesday that it has finalized the sale of its U.S. and South America contact-lens business to a competitor. The sale of the business to Ocular Sciences in San Francisco was announced in April. Company officials said that Allergan was selling off the segment of its operations because it is too competitive and because the company wants to concentrate on its line of pharmaceuticals for eyes and skin.
BUSINESS
August 6, 1997 | (Bloomberg News)
Hall Kinion & Associates Inc. shares rose nearly 30% in their first day of trading amid optimism about prospects for the staffing company, which provides highly skilled workers to technology companies. Shares of the company rose $4.13 to close at $19.13 in Nasdaq trading of 1.59 million shares. Earlier the shares touched $20.25 after a $37.7-million initial public sale of 2.52 million shares. The Cupertino-based company sold 1.
BUSINESS
May 31, 2000 | CATHERINE DODGE, BLOOMBERG NEWS
Ciba Vision, a unit of European drug maker Novartis, reached an agreement Tuesday to buy Wesley Jessen VisionCare Inc., the largest maker of colored contact lenses, for about $785 million, beating a hostile bid from Bausch & Lomb Inc. As a result of the Ciba Vision agreement, Wesley Jessen said it's canceling its planned $386.2-million purchase of disposable-lens maker Ocular Sciences Inc. and paying a $25-million termination fee. The $38.
BUSINESS
August 1, 2001 | JOSH FRIEDMAN, TIMES STAFF WRITER
Micro-cap funds, which hold the smallest of the small stocks, are the hottest little thing in the mutual fund business these days. Twenty-eight of the 38 funds Morningstar Inc. classifies as micro-cap have posted double-digit gains so far in 2001, while large-stock growth funds, the mainstay of many a portfolio, are down 19% as a group year-to-date.
BUSINESS
April 29, 1992 | JAMES M. GOMEZ, TIMES STAFF WRITER
Allergan Inc. said Tuesday that it has agreed to sell its contact-lens business in North and South America to a San Francisco firm, saying that profits from the 5-year-old venture have been disappointing. Ocular Sciences Inc., a contact-lens manufacturer, has signed the agreement to take over Allergan's four contact-lens production facilities. One facility is in Toronto and three more are in Santa Isabel, Puerto Rico. The sale is expected to be completed in midsummer, company officials said.
Los Angeles Times Articles
|